C-MER medical holdings repurchases shares, boosting treasury

C-MER Medical Holdings Limited announced a next day disclosure return on November 20, 2025, detailing a repurchase of 120,000 ordinary shares on the Exchange. These shares were repurchased at an aggregate price of HK$216,700, with an average repurchase price per share ranging from HK$1.80 to HK$1.81. This transaction increased the number of shares held as treasury shares from an opening balance of 16,528,000 to 16,648,000.

The repurchase represents a 0.0097% change in the number of issued shares (excluding treasury shares) prior to the event. The company's total number of issued shares remains unchanged at 1,255,560,870. The shares were repurchased under a mandate granted on May 19, 2025, which authorized the repurchase of up to 125,556,087 shares.

Following this repurchase, C-MER Medical Holdings now holds 120,000 shares repurchased on November 20, 2025, as treasury shares. The company also confirmed the repurchases comply with Main Board Rules and that no material changes have been made to the Explanatory Statement dated April 23, 2025. A moratorium period for new share issues or sales of treasury shares after this repurchase extends up to December 20, 2025.